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Abstract  33 
 34 
Oropouche virus (OROV) is a medically important orthobunyavirus, which causes 35 
frequent outbreaks of a febrile illness in the Northern parts of Brazil. However, despite 36 
being the cause for an estimated half a million human infections since its first isolation 37 
in Trinidad, 1955, details of the molecular biology of this tripartite, negative-sense RNA 38 
virus remain limited. We have determined the complete nucleotide sequence of the 39 
Brazilian prototype strain of OROV, BeAn 19991, and found a number of differences 40 
compared to sequences in the database. Most notable were that the S segment 41 
contains an additional 204 nucleotides at the 3’ end and that there is a critical 42 
nucleotide mismatch at position 9 within the base-paired terminal panhandle structure 43 
of each genome segment. In addition, we obtained the complete sequence of the 44 
Trinidadian prototype strain TRVL 9760 that showed similar characteristics to the 45 
BeAn 19991 strain. By using a T7 RNA polymerase-driven minigenome system, we 46 
demonstrated that cDNA clones of the BeAn 19991 L and S segments expressed 47 
functional proteins and also that the newly determined terminal untranslated 48 
sequences acted as functional promoters in the minigenome assay. By co-transfecting 49 
a cDNA to the viral glycoproteins, virus-like particles (VLP) were generated that 50 
packaged a minigenome and were capable of infecting naive cells.  51 
  52 
 4 
Introduction  53 
 54 
Oropouche virus (OROV) is one of the most important arboviruses in Brazil, after 55 
Dengue virus and yellow fever virus, and was first isolated in 1955 from a febrile 56 
patient in Trinidad (Anderson et al., 1961).  Subsequently, the virus was isolated in 57 
Brazil in 1960 from the blood of a pale-throated three-toed sloth, Bradypus tridactylus, 58 
at a forest camp-site during construction of the Belem-Brasilia highway, just before the 59 
first documented epidemic in Brazil in 1961 (Pinheiro et al., 1962). It is estimated that 60 
half a million OROV infections have occurred in more than 30 outbreaks since the 61 
virus became recognised, but it is probable that the actual numbers are much higher 62 
as cases may be masked by other febrile illnesses, such as Dengue or Mayaro fever, 63 
and diseases caused by other orthobunyaviruses such as Guama virus, that are 64 
prevalent in the region (reviewed in (Vasconcelos et al., 2011). OROV has also been 65 
isolated from various mosquito species (e.g. Coquillettidia venezuelensis, 66 
Ochlerotatus serratus) but during epidemics, OROV is transmitted to humans by the 67 
biting midge Culicoides paraensis (Pinheiro et al., 1981a; Pinheiro et al., 1982; 68 
Pinheiro et al., 1981b). 69 
 70 
OROV belongs to the Simbu serogroup of the genus Orthobunyavirus, which includes 71 
a number of veterinary pathogens such as Akabane (AKAV), Aino, Shuni, Sabo and 72 
Douglas viruses, as well the newly emerged Schmallenberg virus (SBV) (Afonso et al., 73 
2014). OROV is currently the only known human pathogen in the serogroup and recent 74 
phylogenetic analysis (Ladner et al., 2014b) places it in a clade separate to the other 75 
members. Like all bunyaviruses the OROV genome consists of three segments of 76 
single-stranded negative-sense RNA designated large (L), medium (M) and small (S). 77 
The L segment encodes the viral polymerase (L protein) and the M segment encodes 78 
the glycoproteins Gn and Gc, along with a non-structural protein called NSm. The S 79 
segment encodes the viral nucleocapsid protein (N) and a second non-structural 80 
protein, NSs, in over-lapping reading frames, though both proteins are translated from 81 
the same mRNA (Elliott, 2014; Plyusnin & Elliott, 2011). The terminal sequences at 82 
the 3’ and 5’ ends of each segment are complementary, allowing the formation of a 83 
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panhandle structure that is crucial for genome replication and transcription (Barr et al., 84 
2003; Barr & Wertz, 2004; Kohl et al., 2004). 85 
 86 
The epidemiology and genetic variation of OROV has been widely studied, and 87 
phylogenetic analysis of numerous partial S segment sequences (mainly N ORF 88 
sequences), together with more limited partial sequence data on the M and L 89 
segments, suggests the existence of four genotypes (reviewed in (Vasconcelos et al., 90 
2011). However, much less is known about the general molecular biology of OROV or 91 
virus-host interactions. To facilitate such investigations we intend to develop a reverse 92 
genetics system for OROV, as has been reported for other orthobunyaviruses (Elliott, 93 
2012) including two Simbu group viruses AKAV (Ogawa et al., 2007) and SBV (Elliott 94 
et al., 2013; Varela et al., 2013). When we produced cDNA clones of the OROV 95 
genome segments, we noticed several discrepancies between the viral sequences we 96 
obtained and the sequences in the database, notably that the S segment contains an 97 
additional 204 nucleotides. The functionality of our cDNA clones was confirmed by 98 
establishing minigenome (Blakqori et al., 2003; Weber et al., 2002) and virus-like 99 
particle (VLP; (Shi et al., 2007) systems. Our results highlight the importance of 100 
obtaining complete and correct viral sequences, including direct confirmation of the 101 
genome termini, in order to establish reverse genetic systems.  102 
 103 
Results 104 
 105 
Cloning and sequence determination of the genome of Oropouche virus strain 106 
BeAn 19991. Total RNA was extracted from BHK-21 cells infected with OROV strain 107 
BeAn 19991 (prototype Brazilian strain isolated from B. tridactylus) and reverse 108 
transcribed using random primers. Segment-specific oligonucleotides, based on 109 
available complete sequences in the database (L, NC_005776.1 (Aquino et al., 2003); 110 
M, NC_005775.1 (Wang et al., 2001); and S, NC_005777.1; Aquino et al., 111 
unpublished), were used in PCR (Table 1). Full-length cDNAs were cloned into the T7 112 
RNA polymerase transcription plasmid TVT7R(0,0) (Johnson et al., 2000);  the inserts 113 
included an extra G residue at their 5’ ends for efficient T7 transcription, and the 114 
cDNAs were cloned such that T7 polymerase would transcribe antigenome-sense 115 
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RNAs, as previously described (Elliott et al., 2013). Descriptions of the sequences in 116 
this paper are presented for the anti-genomic sense RNA, in the conventional 5’ – 3’ 117 
orientation. 118 
 119 
L segment. The full-length L segment sequence that we obtained was 6852 nt in length, 120 
6 nt longer than the database deposition NC_005776.1. Alignment of our sequence 121 
with that of NC_005776.1 revealed a number of differences in the region from 122 
nucleotide positions 2405 to 2450 and from 2592 to 2617, resulting in amino acid 123 
changes in the region from 798 to 812, and from 860 to 867  (Fig. 1). We verified the 124 
sequence of this region by RT-PCR amplification of a fragment from nt 2130 to 2980 125 
using specific primers and viral RNA as template. Furthermore, alignment of our 126 
sequence with partial sequences of the L segments of OROV strains TRVL-9760, 127 
GML-444479 and IQT-1690 (accession numbers KC759122.1, KC759128.1 and 128 
KC759125.1 respectively) revealed that, apart from a few variations at the nucleotide 129 
level, the translated amino acid sequence for this region is conserved (Fig. 1). 130 
Therefore we consider the published sequence for BeAn 19991 L segment contains 131 
some errors in this region. In addition, we noted two other amino acid differences: L to 132 
F at position 415 and N to D at position 1021. Both of these have been confirmed by 133 
independent sequence analysis of our stock of virus, and the F residue at position 415 134 
is also found in the L protein of other strains of OROV (TRVL-9760, GML-444479 and 135 
IQT-1690). 136 
 137 
The terminal sequences of the L segment UTRs were determined by a 3’ RACE 138 
procedure on total infected cell RNA, using oligonucleotides designed to anneal to 139 
either the genomic or anti-genome strands. Position 9 of the 5’ UTR was determined 140 
as a C residue and the corresponding -9 position in the 3’ UTR as an A residue, 141 
resulting in the characteristic mismatch that has been observed in the predicted 142 
panhandle structure of other orthobunyavirus genome segments (Kohl et al., 2004).  143 
This mismatch is not recorded in the published sequence. Additionally, position 18 at 144 
the 5’ end was determined to be a U rather than a C residue as in the published 145 
sequence  (Fig. 2).  146 
 147 
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M segment. The full length M segment was determined to be 4385 in length, in 148 
agreement with the published sequence. There were a small number of nucleotide 149 
variations compared to the database entry (NC_005775.1), six of which resulted in 150 
amino acid differences: I274F, F587L, K614N, D750G, K981Q and G982S changes. 151 
The sequences encoding these residues were confirmed in independent cDNA clones 152 
of the M segment cDNA and also by specific RT-PCR amplification of appropriate 153 
regions of the viral RNA. Results from RACE analysis revealed two single nucleotide 154 
differences in the 5’ UTR (C at position 9 and A at position 15) and one difference at 155 
the 3’ end (U at position 15) compared to the database sequence. Thus the predicted 156 
panhandle has a C-A mismatch at position 9/-9 and a U-A pairing at position 15/-15 157 
(Fig. 2) 158 
 159 
S segment. The PCR reaction to amplify the S segment surprisingly generated 2 160 
products of approximately 750 bp and 1000 bp in size (Fig. 3A). After cloning, the 161 
sequences of both products were determined. The nucleotide sequence of the smaller 162 
fragment was identical to the database entry NC_005777 (Aquino et al., unpublished) 163 
that is described as “Oropouche virus segment S, complete genome”, but no strain 164 
designation is given. Saeed et al. (2000) reported the complete sequence of the TRVL 165 
9760 strain of OROV also to be 754nt long, though the database entry (accession no. 166 
AF164531) only gives the coding sequence for this strain. In addition, the sequence 167 
of the N ORF of the BeAn 19991 was also reported by Saeed et al. (accession no. 168 
AF164531) and the amino acid sequence is identical to that that we obtained.  169 
 170 
The larger fragment contained an additional 204 nucleotides after the apparent 171 
consensus 3’ terminal sequence in the database entry (Fig. 3B).  172 
 173 
The DNA products were extracted from the gel and used as templates in further PCR. 174 
The shorter template gave rise to a single, similarly sized amplicon, whereas the 175 
longer template again generated products approx 750 bp and 1000 bp in length (Fig. 176 
3C). To investigate this observation further, we amplified the S segment of a clinical 177 
isolate of OROV (H759025 AMA2080; Tilston-Lunel et al., in preparation) using the 178 
same primers and PCR conditions that were used for BeAn 19991, and again 179 
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observed two amplified DNA fragments (data not shown). The sequences of both of 180 
these amplicons largely matched that of the BeAn 19991 products (data not shown).  181 
 182 
Inspection of the “long” sequence showed that nt 735 – 752 could allow annealing of 183 
the primer used in PCR (Fig. 3D). Thus, binding to the primer to this internal sequence 184 
in the S segment would result in a cDNA product with a terminus matching that of the 185 
orthobunyavirus consensus sequence, making it appear complete. Using 3’ RACE and 186 
RNA ligation methods we confirmed that the OROV S segment did indeed contain the 187 
additional 204 nt at the 3’ end (data not shown). Therefore the full-length OROV S 188 
segment is 958 nt in length. 189 
 190 
The corrected sequences of the OROV strain BeAn 19991 genome have been 191 
deposited in the databases with accession numbers KP052850 (L), KP052851 (M), 192 
and KP052852 (S). 193 
 194 
Sequence determination of the Oropouche virus TRVL 9760 strain. Determination 195 
of the complete sequence of another strain of OROV, the Trinidadian prototype TRVL 196 
9760, was carried out independently from that of the BeAn 19991 strain. Total RNA 197 
was extracted from infected murine IFNAR-/- cells and reverse transcribed using 198 
random hexamer primers. Sequences comprising the L, M and N ORFs were amplified 199 
by RT-PCR using specific oligonucleotides based on the sequences available in the 200 
database (L, NC_005776.1; M, NC_005775.1; and S, NC_005777.1, as described 201 
above). While the N ORF sequence was completely amplified in one step, the L and 202 
the M ORF sequences were amplified as six (L) or three (M) overlapping fragments. 203 
The resulting cDNAs were inserted into the TA-vector pCRII, and their sequences 204 
were determined by Sanger sequencing. In comparison to the BeAn 19991 L ORF 205 
sequence NC_005776.1, the TRVL 9760 L ORF contained 151 nucleotide exchanges, 206 
7 single nucleotide insertions and 1 single nucleotide deletion. While 134 of the 151 207 
nucleotide exchanges were silent, the nucleotide insertions and deletions which were 208 
found from nucleotide positions 2405 to 2446 and from 2592 to 2617 lead to several 209 
amino acid exchanges and the insertion of two additional amino acids at position 799 210 
and 810 (Figure 1). The majority of the amino acid substitutions caused by single 211 
 9 
nucleotide exchanges were found in the N-terminal half of the L ORF (A136T, M145V, 212 
N210S, N273D, Q308K, S313N, I355V, F415L, D442N, T479A, I558M, T640A, S921N, 213 
L974I, S1021N) while only three exchanges were found in the C-terminal half (T1159I, 214 
E2056G, R2241K). When compared to the BeAn 19991 M ORF sequence 215 
NC_005775.1, the TRVL 9760 M ORF showed 100 nucleotide exchanges with 15 of 216 
them leading to amino acid substitutions (S12G, I13V, L67P, A244V, I274F, T463I, 217 
A609T, K615N, V732L, D750G, R801K, V846I, S849G, V1241I, M1363I). For the 218 
TRVL 9760 N ORF we detected 13 nucleotide exchanges in comparison to the BeAn 219 
19991 N ORF sequence NC_005777.1, but none of these exchanges leads to an 220 
amino acid substitution. Three of these nucleotide exchanges also affect the 221 
overlapping NSs ORF and two of them lead to amino acid exchanges (K13R and 222 
N74S). 223 
 224 
To determine the sequence of the complete L, M and S segments, pyrosequencing 225 
was performed. OROV genomic RNA isolated from supernatants of infected murine 226 
IFNAR -/- cells was converted to dsDNA by whole transcriptome amplification, which 227 
served as starting material for a shotgun library preparation. After pyrosequencing of 228 
the shotgun library de novo assembly with the obtained sequence reads was 229 
performed which resulted in sequences for the OROV L, M and the S ORFs identical 230 
to those obtained by Sanger sequencing. It was not, however, possible to determine 231 
the sequences of the non-coding regions by de novo assembly. Therefore, an 232 
additional reference mapping was performed using the OROV genomic segment 233 
sequences from the database as reference. With this approach we were able to map 234 
the obtained sequence reads to the complete L and the M segment sequences 235 
NC_005776.1 and NC_005775.1. In the case of the S segment, however, it was not 236 
possible to map the sequence reads to the 3’ end of the S segment sequence 237 
NC_005777.1 but mapping was possible for the 5’ non-coding end and the N ORF. 238 
We therefore performed another round of reference mapping using an S segment 239 
fragment comprising the 5’ end and the N ORF of NC_005777.1 as reference 240 
sequence. Using this approach the reference mapping resulted in an S segment 241 
sequence with 204 additional nucleotides at the 3’ end.  242 
 243 
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The complete sequences of the OROV strain TRVL 9760 genome segments have 244 
been deposited in the databases with accession numbers KP026179 (L), KP026180 245 
(M) and KP026181 (S). 246 
 247 
Establishment of an OROV minigenome system. Minigenome systems have been 248 
described for a number of orthobunyaviruses, and comprise a negative-sense genome 249 
analogue encoding a reporter gene that is packaged into ribonucleoprotein complex 250 
(RNP), transcribed and replicated by co-expressed viral N and L proteins, leading to 251 
measurable reporter activity (Elliott, 2012). After confirmation of the nucleotide 252 
sequences, the open reading frames (ORF) in each segment were amplified by PCR 253 
and subcloned into the pTM1 expression vector (Moss et al., 1990). Minigenome 254 
constructs were created by replacing the viral ORF in each segment with the sequence 255 
for Renilla luciferase, and then inverting the insert in plasmid TVT7R (0,0) (Johnson 256 
et al., 2000) so that T7 transcripts would be in the genomic sense (Weber et al., 2001). 257 
We first used a minigenome based on the OROV M segment, as studies with BUNV 258 
showed the M segment minigenome to be the most active (Barr et al., 2003). However, 259 
initial attempts using the M segment UTR sequences as reported in the database gave 260 
low activity over background. When we subsequently obtained the M segment terminal 261 
sequences by 3’ RACE analysis and redesigned the minigenome accordingly, with the 262 
C-A mismatch at position 9/-9, high levels of luciferase activity were observed, 263 
indicating that, firstly, both N and L protein expressing constructs were functional and, 264 
secondly, that the M segment UTR sequences determined herein were active 265 
promoters. The amounts of transfected N- and L- expressing plasmids were titrated to 266 
determine the optimal amounts that gave maximum luciferase activity (data not 267 
shown) and the optimised amounts used in all further experiments.  268 
 269 
The effects of nucleotide differences in M segment UTR on minigenome activity are 270 
compared in Figure 4A. The minigenome with UTR sequences as previously published 271 
(9C:G, 15C:G) showed low activity, whereas the minigenome with UTR sequences as 272 
determined in our work (9C:A, 15U:A) showed over 2,000-fold increased activity over 273 
background (cells where no L expressing plasmid was transfected). However, it was 274 
not just the mismatch at position 9/-9 that was critical for maximal activity, but also the 275 
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base-pairing at position 15/-15, as the minigenome with the position 9 C:A mismatch 276 
but C:G at position 15/-15 showed only 500-fold increase in activity. Introduction of the 277 
U:A pairing was not able to rescue activity when position 9/-9 was C:G, and other 278 
nucleotide combinations at position 15 were less active than U:A. Taken together, 279 
these results highlight the importance of certain residues within the M segment 280 
promoter. 281 
 282 
The minigenome assay was also used to compare the short and long S segment UTR 283 
sequences (Fig. 4B). Minigenome constructs contained the same 5’ UTR and either 284 
the 14nt (as previously published) or 218nt (as determined herein) long 3’ UTR. The 285 
minigenome with the short UTR was inactive whereas the minigenome with the 218nt 286 
3’ UTR showed robust luciferase activity. Lastly, we compared L segment derived 287 
minigenomes, with either a C or U residue at position 18 in the 5’ UTR. Both 288 
minigenomes gave similar high luciferase activity (Fig. 4C). 289 
 290 
Together, these results confirmed that the N and L proteins were functional in a 291 
minigenome assay, and also that the UTR sequences as determined for the S, M and 292 
L segments were functional promoters, and that a base mismatch at position 9/-9 was 293 
critical for promoter activity. 294 
 295 
Virus-like particle production assay. To investigate whether the glycoprotein gene 296 
was also functional, a VLP assay was developed. In addition to M segment 297 
minigenome, N and L expressing plasmids, cells were also transfected with a plasmid 298 
expressing the glycoprotein precursor. Luciferase activity was measured in these 299 
donor cells at 24 and 48 h post transfection (Fig. 5A), and it was noted that there was 300 
a significant increase in luciferase activity in cells additionally transfected with the 301 
glycoprotein cDNA at 48 h, suggesting spread of VLPs within the culture. The 302 
supernatants from transfected cells were harvested at 48 h post transfection and 303 
transferred onto naïve BHK cells; luciferase activity in these cells was measured 24 h 304 
later. High levels of luciferase activity were recorded in cells exposed to supernatants 305 
expressing the glycoproteins (column L + M in Fig 5B) compared to those exposed to 306 
supernatants from cells not transfected with the glycoprotein cDNA (column L). This 307 
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is a stringent assay relying only on transcription of the packaged minigenome in the 308 
VLP without the need for exogenously supplied viral N and L proteins. Incubation of 309 
the supernatant with antibodies to OROV before infection markedly reduced luciferase 310 
expression, whereas incubation with an irrelevant antiserum (anti-BUNV serum) had 311 
no effect (Fig. 5B). Taken together these results indicate that the OROV glycoprotein 312 
gene cDNA was functional in this VLP assay. 313 
 314 
Discussion 315 
 316 
A crucial step in developing reverse genetic systems for RNA viruses is obtaining 317 
cDNA clones that are representative of the authentic viral genome sequence. As 318 
described above, we found a number of sequence differences in our clones derived 319 
from the BeAn 19991 strain compared to sequences in the database, including approx. 320 
200 additional nucleotides at the 3’ end of the S genome segment, an apparent frame 321 
shift in the L segment coding sequence and a critical mismatched nucleotide pair in 322 
the terminal panhandle sequence on each segment. These significant differences 323 
were confirmed when the complete sequence of the Trinidadian prototype strain TRVL 324 
9760 was also determined. 325 
 326 
Early studies comparing orthobunyavirus genome sequences indicated that the 327 
terminal 11 nucleotides of each segment exhibited a high degree of conservation, and 328 
hence consensus primers based on sequences of Bunyamwera and California 329 
serogroup viruses (Dunn et al., 1994; Elliott, 1989a; b; Elliott et al., 1991) have 330 
traditionally been used to amplify unknown bunyavirus genomes. However, the actual 331 
terminal sequences for the majority of sequences currently available in the database 332 
have not been verified directly, for example by RACE techniques. With regard to the 333 
orthobunyavirus “consensus sequence” there is a single nucleotide difference 334 
between the 3’ and 5’ complementary ends such that, using total infected cell RNA as 335 
template, mispriming by either primer could occur, or a single primer could bind to both 336 
genomic and antigenomic RNAs. Indeed, a single primer was used to amplify the 337 
OROV M segment (Aquino & Figueiredo, 2004) or the S segments of a range of 338 
orthobunyaviruses (Lambert & Lanciotti, 2008). The importance of the terminal 339 
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sequence has been investigated by minigenome assays for BUNV (Dunn et al., 1995; 340 
Kohl et al., 2003; Kohl et al., 2004) (Barr et al., 2003) (Barr & Wertz, 2004) and the 341 
mismatch at position 9/-9 was shown to be crucial for promoter activity (Barr & Wertz, 342 
2005). As more diverse orthobunyavirus genomes have been sequenced, particularly 343 
using next generation sequencing methods (deep sequencing) that are not reliant on 344 
specific primers to amplify cDNA, it has become clear that there is more variation in 345 
the “bunyavirus consensus” than observed between Bunyamwera and California 346 
serogroup viruses (e.g.(Ladner et al., 2014b)), highlighting the requirement for direct 347 
determination of the terminal sequences. In a similar vein, as the genomes of more 348 
phleboviruses (that constitute another genus in the Bunyaviridae family) have been 349 
sequenced, it is apparent that the termini also diverge from the “phlebovirus 350 
consensus” (Dilcher et al., 2012a; Elliott & Brennan, 2014; Matsuno et al., 2013). 351 
 352 
A recent paper (Ladner et al., 2014a) has suggested the standards that should be 353 
applied to viral genome sequence determination and we strongly support the 354 
recommendations proposed therein. 355 
 356 
In 2000, Saeed and others reported the first nucleocapsid gene sequences of 28 357 
strains of OROV, including the prototypic Trinidadian OROV isolate TRVL 9760 and 358 
the Brazilian isolate BeAn 19991 (Saeed et al., 2000). They determined the complete 359 
S segment to be 754 bases and noted the unusually short length of the 3’ UTR, just 360 
14 bases after the translational stop codon, compared to other orthobunyavirus S 361 
segments. They employed various experimental procedures to verify the 3’UTR 362 
including chemical denaturation of the purified viral RNA with methylmercury 363 
hydroxide before RT-PCR (in case there was a secondary structure that impeded 364 
reverse transcription), and a 5’ RACE procedure using both purified viral RNA and 365 
total cellular RNA as starting material (Saeed et al., 2000). All approaches yielded that 366 
same short 3’UTR.  Our results indicate that the true length of the S segment is actually 367 
958 nt which was verified by independent experimental analyses, including deep-368 
sequencing of the TRVL 9760 strain. Examination of the correct sequence reveals an 369 
internal region highly similar to the terminal sequence that could hybridise with the 370 
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primer, and in our studies resulted in two PCR products. The functionality of the longer 371 
3’UTR determined in this study was demonstrated in the minigenome assay.  372 
 373 
We further confirmed that the sequences of the BeAn 19991 N and L proteins were 374 
functional in driving reporter gene expression from minigenomes, and similarly that 375 
the determined UTR sequence for all three segments could be used to construct 376 
functional minigenomes. Lastly, by cotransfecting a cDNA that expressed the 377 
glycoprotein gene, we produced virus like particles that were capable of packaging a 378 
minigenome and to infect naïve cells. Together these data provide strong evidence 379 
that the cDNA clones reported in this paper are fully functional and pave the way to 380 
establishing a virus rescue system. The availability of such a system will play a crucial 381 
role in understanding the molecular biology of this important yet poorly characterised 382 
emerging viral zoonosis. The corrected sequences of the BeAn 19991 and TRVL9670 383 
genome segments have been deposited in the database. 384 
 385 
 386 
Methods and Materials 387 
 388 
Cells and Virus 389 
Vero-E6 and murine IFNAR -/- cells were grown in Dulbecco’s modified Eagle’s 390 
medium (DMEM, Invitrogen) supplemented with 10% foetal calf serum (FCS). BHK-391 
21 cells were grown in Glasgow minimal essential medium (GMEM, Invitrogen) 392 
supplemented with 10% newborn calf serum (NCS) and 10% tryptose phosphate broth 393 
(TPB, Invitrogen). BSR-T7/5 cells, which stably express T7 RNA polymerase 394 
(Buchholz et al., 1999), were grown in GMEM supplemented with 10% FCS, 10% TPB 395 
and 1 mg/ml G418 (Geneticin; Invitrogen).  396 
OROV strain BeAn 19991 was kindly donated by Prof. Luiz Tadeu Moraes Figueiredo, 397 
from the Ribeirao Preto School of Medicine, University of Sao Paulo, Brazil, and strain 398 
TRVL 9760 was kindly provided by Dr. Robert Shope from the University of Texas 399 
Medical Branch in Galveston, USA. A sample of total infected cell RNA obtained from 400 
the strain H759025 AMA2080 was provided by Dr. Pedro Vasconcelos, from the 401 
Department of Arboviruses and Hemorrhagic Fevers, Brazil. 402 
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All experiments with infectious viruses were conducted under CL3 laboratory 403 
conditions.  404 
 405 
Cloning of OROV cDNA 406 
OROV was grown in BHK-21 cells at 37°C and after 30 h both cells and supernatant 407 
were harvested, and RNA extracted using TRIzol reagent (Invitrogen). cDNAs to each 408 
segment were  synthesised separately, using segment-specific primers for the L and 409 
M segments (OROLFg and OROMFg, Table 1), and random primers (Promega) for 410 
the S segment, together with M-MLV reverse transcriptase (Promega). Each cDNA 411 
preparation was used in a segment specific PCR using the appropriate primer pairs 412 
(OROMFg and OROMRg for the M segment, and OROSFg and OROSRg for the S 413 
segment; Table 1) and KOD Hot Start DNA polymerase (Merck), according to the 414 
manufacturer’s protocol.  The full-length PCR products were cloned into pGEM-T Easy 415 
(Promega). After selection of positive clones, the inserts were excised by digestion 416 
with BsmBI and ligated into BbsI-linearized plasmid TVT7R(0,0) (Johnson et al., 2000). 417 
The L segment cDNA was amplified in two fragments using primer pairs (OROFLg 418 
and OROL1, and OROL2 and OROLRg; Table 1). The first primer pair amplified nt 1 419 
to 3706, and the second pair nt 3537 to 6852, resulting in two PCR products with a 420 
170 bp overlapping region containing a unique BsgI restriction site (position 3590 in 421 
the full length segment). PCR products were purified from an agarose gel and then 422 
cloned into pGEM-T Easy. The inserts were excised by digestion with restriction 423 
enzymes BsgI and BsmBI, and the full-length L segment was assembled by ligating 424 
both fragments with BbsI-linearized  TVT7R(0,0). The cDNA inserts included an extra 425 
G residue at their 5′ ends for efficient T7 transcription, and the inserts were cloned 426 
such that T7 polymerase would transcribe antigenome-sense RNAs. The plasmids 427 
were named pTVTOROVL, pTVTOROVM and pTVTOROVS.  428 
 429 
Construction of protein-expressing and minigenome-expressing plasmids. 430 
The complete open reading frames (ORF) in the L and M segments were amplified by 431 
PCR using specific primers (pTM1 series in Table 1) and the pTVT7 transcription 432 
plasmids as templates, and subcloned into expression vector pTM1 (Moss et al., 1990), 433 
under the control of the T7 promoter and encephalomyocarditis virus internal ribosome 434 
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entry site sequence (IRES). The constructs were called pTM1OROV-L and 435 
pTM1OROV-M. To generate a plasmid expressing only the N protein we introduced 436 
three point mutations (T68C, T113C and G116A) into pTVTOROVS, using primers 437 
OROdelNSsF and OROdelNSsR (Table 1), by QuikChange Site-directed Mutagenesis 438 
(Stratagene), prior to PCR amplification of the N ORF. These mutations changed the 439 
first and second methionine codons in the NSs ORF into threonine codons, and 440 
introduced an in-frame translation stop codon at codon 17; the coding sequence of the 441 
overlapping N ORF was unaffected. This plasmid was designated pTM1OROV-N. 442 
 443 
The minigenome plasmids were created in three steps. First, the sequence encoding 444 
the coding sequence in each pTVT7 clone was deleted by excision PCR, leaving the 445 
UTRs intact. These linearised DNAs were then used in an In-Fusion reaction (In-446 
Fusion HD Cloning, Clontech) with PCR-amplified DNA of the Renilla luciferase gene. 447 
The amplified luciferase gene contained 15 nt extensions homologous to the OROV 448 
L, M or S segment UTR sequences in the linearised pTVT7 construct. The UTR-449 
luciferase-UTR sequence was then amplified by PCR using primers containing 15 nt 450 
extensions homologous to the T7 terminator (5’ end) and T7 promoter (3’ end). This 451 
amplified products were combined with TVT7R(0,0) DNA in an In-Fusion reaction to 452 
generate minigenome-expressing plasmids such that in T7 transcripts  the  Renilla 453 
luciferase was in the negative-sense. These constructs were designated 454 
pTVT7OROVSRen(-), pTVT7OROVMRen(-) and pTVT7OROVLRen(-). 455 
 456 
Sequencing OROV BeAn 19991 5’ and 3’ termini  457 
As total infected cell RNA contains both genomic and anti-genomic segments, 3’ 458 
RACE analysis would be capable of generating both the 5’ and 3’ terminal sequences 459 
using strand specific primers. Briefly, RNA was polyadenylated (Ambion kit) for 1 hour 460 
at 37°C and then purified using the RNeasy minikit (Qiagen). The polyadenylated RNA 461 
was then used in a reverse transcription reaction with M-MLV reverse transcriptase 462 
(Promega) and oligo d(T) primer, followed by PCR using 3’ PCR anchor primer 463 
(Roche) and the appropriate segment specific primer (OROVL_anti and OROVL_gen 464 
for the L segment, and OROVM_anti and OROVM_gen for the M segment; Table 1) 465 
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with KOD Hot Start DNA polymerase (Merck). Amplified products were purified on an 466 
agarose gel and their nucleotide sequence determined.  467 
 468 
To confirm the S segment terminal sequences, total infected cell RNA was first 469 
denatured at 90°C for 3 min and then ligated using T4 RNA ligase (New England 470 
Biolabs) for 2 hours at 37°C. The reaction was heat inactivated at 65°C and purified 471 
using the RNeasy minikit (Quiagen). cDNA was synthesised using M-MVL reverse 472 
transcriptase (Promega) and oligonucleotide OROSlig1 (Table 1). PCR was then 473 
performed with KOD Hot Start DNA polymerase (Merck) and primers OROSlig1 and 474 
OROSlig2 (Table 1). The PCR product was purified on an agarose gel and its 475 
nucleotide sequence determined. 476 
 477 
Pyrosequencing of the OROV TRVL 9760 strain 478 
OROV TRVL 9760 was grown in IFNAR -/- cells at 37°C and after 48 h supernatant 479 
was harvested. (Preliminary results showed that IFNAR-/- cells gave the highest 480 
amounts of genomic RNA in the extracted supernatant compared to Vero-E6 or BHK-481 
21 cells; unpublished observations). For removal of cell debris the supernatant was 482 
centrifuged at 700 x g for 10 min and at 2,800 x g for 5 min followed by filtration through 483 
a 0.2 µm sterile filter. To enrich viral particles 20 ml cleared supernatant was mixed 484 
with 1.48 ml 5M NaCl and 10.8 ml 30% PEG8000 in NTE (100 mM NaCl; 10 mM Tris, 485 
pH 6.5; 1 mM EDTA), incubated on a shaker for 30 min at 4 °C, and subsequently 486 
centrifuged at 6,000 x g for 60 min at 4 °C. The virus pellet was resuspended in 500 487 
μl PBS. RNA extraction was performed using PeqGold Trifast (Peqlab, Erlangen 488 
Germany). To be able to cover the 3’ terminal parts of the OROV genome segments, 489 
500 ng self-complementary FLAC adapters were ligated to 500 ng purified viral RNA 490 
as described (Dilcher et al., 2012b). To achieve coverage of the 5’ terminal parts, a 5’-491 
RACE RNA adapter (Ambion) was ligated to the viral RNA after the removal of two 492 
phosphate groups via RNA 5’-polyphosphatase. To remove unligated adapters a 493 
subsequent purification step was performed using the CleanAll DNA/RNA Clean-Up 494 
and Concentration-Kit (Norgen Biotek). The concentration of the adapter-ligated and 495 
purified ssRNA was determined by Qant-iT RiboGreen Assay (Invitrogen). 60 ng of 496 
the adapter-ligated viral RNA was amplified and converted to dsDNA using the 497 
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TransPlex Whole Transciptome Amplification kit (WTA2, Sigma-Aldrich). The newly 498 
synthesized dsDNA was purified using the QIAquick PCR Purification kit (Qiagen), 499 
and DNA fragments shorter than 350 bp were removed using Ampure-XP beads 500 
(Agencourt). 300 ng of the whole genome amplified dsDNA was used for Titanium 501 
Shotgun Rapid Library Preparation and pyrosequencing on a Genome Sequencer FLX 502 
(Roche) as described in the FLX Titanium Protocol (Roche) but omitting the DNA 503 
fragmentation by nebulization step. Assembly of the sequenced OROV genome 504 
segments was done by means of the Genome Sequencer FLX System Software 505 
Package version 2.3 (GS De Novo Assembler, GS Reference Mapper) in combination 506 
with the commercially available SeqMan Pro Software version 10.1.1 (DNASTAR, 507 
Lasergene). 508 
 509 
 510 
Minigenome and virus-like particle assays 511 
Subconfluent monolayers of BSR-T7/5 cells were transfected with 1 μg each 512 
pTM1OROV-L and pTM1OROV-N, 0.5 μg of a minigenome-expressing plasmid and 513 
100ng pTM1-FF-Luc (Weber et al., 2001). At 24 h post-transfection Renilla and firefly 514 
luciferase activities were measured using Dual-Luciferase Reporter Assay kit 515 
(Promega).  516 
To generate VLPs, the M segment minigenome transfection mix was supplemented 517 
with 0.5 μg pTM1OROV-M.  At 24 and 48 h post-transfection supernatants were 518 
harvested, clarified by centrifugation (4000 rpm for 5 mins at 4oC), digested with 519 
benzonase, and used to infect BHK-21 cells. Renilla activity was measured after 24 h 520 
using the Renilla Reporter Assay kit  (Promega). To neutralise the VLPs, samples 521 
were incubated with hyperimmune mouse ascetic fluid to OROV or with anti-BUNV 522 
rabbit antiserum for 1 h at room temperature before infecting BHK-21 cells. 523 
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Figure Legends 674 
 675 
Figure 1.  Alignment of part of the OROV L segment highlighting the differences 676 
between the published sequence for BeAn 19991 strain (accession number 677 
NC_005776) and the sequence obtained in this study (new data), along with three 678 
published OROV sequences from different genotypes TRVL-9760 (KC759122.1), 679 
GML-444479 (KC759128.1) and IQT-1690 (KC759125.1). The nucleotide alignment 680 
is shown in the top panel and the amino acid alignment in the bottom panel. 681 
Alignments were performed using CLC Genomics Workbench 6.5. 682 
 683 
Figure 2. Comparison of the published and the revised OROV UTR sequences shown 684 
as a panhandle structure. The terminal 11 conserved residues are separated by a 685 
vertical line. Differences are highlighted in red. 686 
 687 
Figure 3. Analysis of the OROV S segment. (A) Agarose gel electrophoresis of the S 688 
segment RT-PCR product. (B) Schematic drawing of OROV S segment, comparing 689 
the published sequence of 754bp (upper drawing) to the newly determined 958bp 690 
sequence (lower drawing). Black boxes represents the N ORF, grey boxes the NSs 691 
ORF, and hatched boxes the UTRs. The sequence is presented in the anti-genomic 692 
5’ to 3’ sense. Numbers indicate the nucleotide position in the sequence. (C) Agarose 693 
gel electrophoresis of reamplified DNA products using the 754bp and the 958bp PCR 694 
products as template. (D) Diagram showing the potential internal binding site (bold) in 695 
the OROV S segment. Numbers represent the nucleotide position. OROSRg Primer: 696 
primer sequence that was used in this paper to amplify the S segment.  697 
 698 
Figure 4. Minigenome assay. (A) Comparison of M segment based minigenomes. 699 
BSR-T7/5 cells were transfected with 1 μg each pTM1OROV-L and pTM1OROV-N, 700 
0.5 μg of M segment minigenome-expressing plasmid and 100 ng pTM1-FF-Luc; the 701 
background control lacked pTM1OROV-L.  M segment minigenomes contained 702 
different nucleotides at position 9/-9 as indicated. Minigenome activity is expressed as 703 
fold induction over the background control. (B) Comparison of S segment 704 
minigenomes containing the published (14 nt) or newly-defined long (218 nt) 5’ UTR. 705 
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(C). Comparison of L segment minigenomes containing a C or U residue at position 706 
18 in the 3’ UTR. 707 
 708 
Figure 5. Virus-like particle production assay. BSR-T7/5 cells were transfected 709 
with 1 μg each pTM1OROV-L and pTM1OROV-N, 0.5 μg pTM1OROV-M, 0.5 μg of 710 
the M segment minigenome-expressing plasmid and 100ng pTM1-FF-Luc; control 711 
transfection mixes lacked pTM1OROV-L (No L) or pTM1OROV-M (+L). At 24 or 48 h 712 
post transfection, clarified supernatants were used to infect naive BHK-21 cells, and 713 
luciferase activity measured 24 h later. (A) Minigenome activity in transfected BSR-714 
T7/5 cells at 24 or 48 h post transfection. (B) Minigenome activity in BHK-21 cells 715 
infected with supernatants from cells in graph A. VLPs were also incubated with anti-716 
OROV antibodies (+ve) or irrelevant antibodies (-ve) before infection of cells as 717 
indicated.   718 
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